Patricia Chévez-Barrios, MD

Former affiliation
  • Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus
1989 …2021

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Personal profile

After finishing all seven of her postdoctoral training programs, Dr. Chévez-Barrios joined the faculty of the Baylor College of Medicine in 1996 as an Assistant Professor in the Department of Pathology, with a secondary appointment in the Department of Ophthalmology. She became a Clinical Assistant Professor in the Department of Ophthalmology there in 2004, and received the Fulbright & Jaworski LLP Award for Faculty Excellence in Teaching and Evaluation and became Associate Member of the Cell and Gene Therapy Center that same year. She has current appointments of adjunct professor in the Department of Pathology at The University of Texas MD Anderson Cancer Center and Department of Ophthalmology at the Baylor College of Medicine. Dr. Chévez- Barrios assumed her current positions at Methodist in 2004.

Research interests

The main research interest of Dr. Chévez-Barrios and her laboratory is the study of retinoblastoma, including cancer stem cells, suicide gene therapy for retinoblastoma, the study of metastatic properties of retinoblastoma and preclinical models of the tumor. Other topics of interest are ocular gene therapy, cataractogenesis, vascular proliferation in hypoxic ocular diseases and corneal diseases. Dr. Chevez-Barrios’ laboratory is currently participating in the project of gene therapy for Retinoblastomas in collaboration with the Texas Children’s Cancer Center and the Center for Gene Therapy of Texas Children's Hospital, and Baylor College of Medicine. Pre-clinical studies and a phase 1 clinical trial of vitreous seed of retinoblastoma have been completed. The phase II clinical trial is in preparation. Dr. Chevez-Barrios is a committee member responsible of evaluating all enucleated eyes from the prospective multicenter study of the ARET0332 Children’s Oncology Group protocol on “A Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy. Dr. Chevez-Barrios is also interested in the biological differences between retinoblastoma cell lines that have the capability of producing metastasis, and those that behave less aggressively and remain as intraocular tumors.

Education/Academic qualification

Pathology, Residency, Baylor College of Medicine

Aug 1 1993Jan 31 1996

Award Date: Jan 31 1996

Ophthalmic Pathology, Clinical Fellowship, Baylor College of Medicine

Feb 1 1990Jun 30 1993

Award Date: Jun 30 1993

MD, Universidad Nacional Autonoma

… → May 31 1986

Award Date: May 31 1986

Research Area Keywords

  • Cancer
  • Infectious Disease & Pathology

Free-text keywords

  • Retinoblastoma
  • Metastasis
  • Gene therapy
  • Neovascularization

Fingerprint

Dive into the research topics where Patricia Chévez-Barrios is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 12 Similar Profiles

Network

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or